Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Hypoglycemia is blood sugar below 70 milligrams (mg) per deciliter (dL ... Ozempic (semaglutide) is not approved for the treatment of type 1 diabetes. Ozempic is a once-weekly injection that helps ...

They have also become increasingly popular after a number of celebrities began using Ozempic, which is primarily used to treat ... Wegovy is taken via an injection once a week. Should you meet the ...

Ozempic is a solution for subcutaneous injection that’s approved by the Food and Drug Administration (FDA) to: An interaction occurs when one substance causes another substance to have a ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk’s diabetes-cum-weight loss drug Ozempic ... injection on major kidney and cardiovascular outcomes in adults with Type 2 diabetes and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...